CEO of Fi-Med, Mr Adrian Velasquez said “I have wanted to provide RPM to our patient base for years. However, the ordering, distribution, installation, patient training and cost have been prohibitive until we met Respiri. The collaboration with Respiri is truly exciting for us. By leveraging Respiri's groundbreaking device, wheezo®, and its integrated technology, we foresee a rapid growth in patients under management and also growth in monthly billable events per patient. We look forward to working collaboratively with Marjan and his team over the coming years to establish our shared approach and deliver substantial value to our respective customers.
Announcement like this and the shares still around 3 Cents - just crazy!
Ann: Wheezo RPM footprint expands with new marketing agreement, page-3
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.002(4.76%) |
Mkt cap ! $51.39M | |||
| Open | High | Low | Value | Volume |
| 4.2¢ | 4.3¢ | 3.7¢ | $301.9K | 7.521M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 369145 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 131324 | 1 |
View Market Depth
| Last trade - 15.45pm 04/10/2024 (20 minute delay) ? |
| RSH (ASX) Chart |